Hyperkalemia as a limiting factor of Neurohormonal Blockade/Modulation in everyday clinical practice
Aims Neurohormonal (NH) blockade/modulation is the core of Heart Failure with reduced Ejection Fraction (HFrEF) therapy. While improving long-term prognosis, it also induces hyperkalemia, which may increase mortality in the short-term. Thus, hyperkalemia frequently leads to withholding or reducing N...
| Autor principal: | |
|---|---|
| Formato: | masterThesis |
| Idioma: | eng |
| Publicado em: |
2020
|
| Assuntos: | |
| Texto completo: | https://hdl.handle.net/10216/128673 |
| País: | Portugal |
| Oai: | oai:repositorio-aberto.up.pt:10216/128673 |